SARS-CoV-2 papain-like protease (PLpro) inhibitory and antiviral activity of small molecule derivatives for drug leads

被引：6
|
作者：
Ghosh, Arun K. [1 ,2 ]
Shahabi, Dana [1 ,2 ]
Imhoff, Mackenzie E. C. [3 ]
Kovela, Satish [1 ,2 ]
Sharma, Ashish [1 ,2 ]
Hattori, Shin-ichiro [4 ]
Higashi-Kuwata, Nobuyo [4 ]
Mitsuya, Hiroaki [4 ,5 ,6 ]
Mesecar, Andrew D. [7 ]
机构：
[1] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA
[2] Purdue Univ, Dept Med Chem, W Lafayette, IN 47907 USA
[3] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA
[4] Natl Ctr Global Hlth & Med, Dept Refractory Viral Dis, Shinjuku Ku, Tokyo 1628655, Japan
[5] Kumamoto Univ Hosp, Dept Clin Sci, Kumamoto 8608556, Japan
[6] Natl Canc Inst, HIV & AIDS Malignancy Branch, Expt Retrovirol Sect, Bethesda, MD 20817 USA
[7] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2023年 / 96卷
关键词：
Antiviral; Covid-19; Inhibitor; SARS-CoV-2; protease; Synthesis;
D O I：
10.1016/j.bmcl.2023.129489
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
We report here the synthesis and biological evaluation of a series of small molecule SARS-CoV-2 PLpro inhibitors. We compared the activity of selected compounds in both SARS-CoV-1 and SARS-CoV-2 PLpro inhibitory and antiviral assays. We have synthesized and evaluated several new structural variants of previous leads against SARS-CoV-2 PLpro. The replacement of the carboxamide functionality with sulfonamide derivatives resulted in PLpro inhibitors with potent PLpro inhibitory and antiviral activity in VeroE6 cells similar to GRL0617. To obtain molecular insight, we created an optimized model of a potent sulfonamide derivative in the SARS-CoV-2 PLpro active site.
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2
    Klemm, Theresa
    Ebert, Gregor
    Calleja, Dale J.
    Allison, Cody C.
    Richardson, Lachlan W.
    Bernardini, Jonathan P.
    Lu, Bernadine G. C.
    Kuchel, Nathan W.
    Grohmann, Christoph
    Shibata, Yuri
    Gan, Zhong Yan
    Cooney, James P.
    Doerflinger, Marcel
    Au, Amanda E.
    Blackmore, Timothy R.
    van der Heden van Noort, Gerbrand J.
    Geurink, Paul P.
    Ovaa, Huib
    Newman, Janet
    Riboldi-Tunnicliffe, Alan
    Czabotar, Peter E.
    Mitchell, Jeffrey P.
    Feltham, Rebecca
    Lechtenberg, Bernhard C.
    Lowes, Kym N.
    Dewson, Grant
    Pellegrini, Marc
    Lessene, Guillaume
    Komander, David
    EMBO JOURNAL, 2020, 39 (18)
  • [2] Fragment-Based Screen of SARS-CoV-2 Papain-like Protease (PLpro)
    Taylor, Ashley J.
    Amporndanai, Kangsa
    Rietz, Tyson A.
    Zhao, Bin
    Thiruvaipati, Anusha
    Wei, Qiangqiang
    South, Taylor M.
    Crow, Mackenzie M.
    Apakama, Chideraa
    Sensintaffar, John L.
    Phan, Jason
    Lee, Taekyu
    Fesik, Stephen W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (08): : 1351 - 1357
  • [3] Drug Repurposing for the SARS-CoV-2 Papain-Like Protease
    Cho, Chia-Chuan
    Li, Shuhua G.
    Lalonde, Tyler J.
    Yang, Kai S.
    Yu, Ge
    Qiao, Yuchen
    Xu, Shiqing
    Ray Liu, Wenshe
    CHEMMEDCHEM, 2022, 17 (01)
  • [4] Genetically Encoded Fluorescent Sensors for SARS-CoV-2 Papain-like Protease PLpro
    Sokolinskaya, Elena L.
    Putlyaeva, Lidia, V
    Polinovskaya, Vasilisa S.
    Lukyanov, Konstantin A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (14)
  • [5] In Silico Identification of Inhibitory Compounds for SARS-Cov-2 Papain-Like Protease
    Miwa, Kazunori
    Guo, Yan
    Hata, Masayuki
    Hirano, Yoshinori
    Yamamoto, Norio
    Hoshino, Tyuji
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2023, 71 (12) : 897 - 905
  • [6] Synthesis and Structure-Activity Relationship of Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease with Antiviral Potency
    Rouch, Catherine C.
    Chatterjee, Arnab K.
    Mccarty, Connor
    Song, Lirui
    Chu, Alan
    Johnson, Kristen
    Heacock, Mina
    Riva, Laura
    Mcnamara, Case W.
    Wolff, Karen C.
    Greene-Cramer, Rebecca
    De Falco, Anna
    Montelione, Gaetano T.
    Grabovyi, Gennadii A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2025, 116
  • [7] Phthalimide derivatives as a new class of papain-like protease inhibitors in SARS-CoV-2
    Fischer, Thomas
    Frasson, David
    Sievers, Martin
    Riedl, Rainer
    ARCHIV DER PHARMAZIE, 2025, 358 (01)
  • [8] Review of the crystallized structures of the SARS-CoV-2 papain-like protease
    Qiu, Yue
    Jiang, Hua-Juan
    Yang, Yu-Shun
    Hu, Xiao-Qin
    Zeng, Xue-Wen
    JOURNAL OF MOLECULAR STRUCTURE, 2025, 1333
  • [9] A cell-based Papain-like Protease (PLpro) activity assay for rapid detection of active SARS-CoV-2 infections and antivirals
    Jimenez-Campos, Anahi G.
    Maestas, Lucas I.
    Velappan, Nileena
    Beck, Brian
    Ye, Chunyan
    Wernsing, Keith
    Mata-Solis, Yaniksa
    Bruno, William J.
    Bussmann, Silas C.
    Bradfute, Steven
    Baca, Justin T.
    Rininsland, Frauke H.
    PLOS ONE, 2024, 19 (12):
  • [10] SARS-CoV-2 Papain-Like Protease: Structure, Function and Inhibition
    Ullrich, Sven
    Nitsche, Christoph
    CHEMBIOCHEM, 2022, 23 (19)
12345